Open Access
Research Paper
Peer Reviewed

Paper Title

ROLE OF SILVER NANOPARTICLES IN THE TREATMENT OF HYPERLIPIDEMIA

Article Identifiers

Registration ID: IJNRD_181925

Published ID: IJNRD2207006

: Click Here to Get

Keywords

Silver nanoparticles, Nanoparticles, Hyperlipidemia, Antihyperlipidemic activity

Abstract

In the recent years, India and other developing nations have seen a quickly raising epidemic of cardiovascular illness. Primary care physicians frequently diagnose and treat hyperlipidemia to avoid cardiovascular disease. The poor absorption characteristics of the active constituents due to their poor water solubility, large molecular sizes which result in a poor diffusion rate. Combining herbal medications with nanotechnology has been advocated because nanostructured systems can overcome the stimulatory effects of plant extracts, reduce the required dose and side effects. Nanoparticles have identified as significant participants in modern medicine, with applications ranging from contrast agents in medical imaging to carriers for gene delivery into individual cells. Silver nanoparticles have tunable physical and chemical properties, so it has been studied widely to improve its applicability. Physicochemical or biological approaches are used to prepare silver nanoparticles, however, each method has its pros and cons. Likewise, biological synthesis is not always reproducible for extensive use but can be a suitable candidate for therapeutic activities like cancer therapy. Excess use of Silver nanoparticles is cytotoxic, and their unregulated discharge in the environment may have effects on both aquatic and terrestrial biota. The research in Silver nanoparticles has always been driven by the need to develop a technology with potential benefits and minimal risk to environmental and human health. In this review, we have attempted to provide an insight into the importance and applications of silver nanoparticles in hyperlipidemia and other pharmacological activities along with the recent synthetic and characterization techniques used for silver nanoparticles.

How To Cite (APA)

AHALAYA R, NOOPUR SRIVASTAVA, & PADMAA M PAARAKH (July-2022). ROLE OF SILVER NANOPARTICLES IN THE TREATMENT OF HYPERLIPIDEMIA. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(7), 46-59. https://ijnrd.org/papers/IJNRD2207006.pdf

Issue

Other Publication Details

Paper Reg. ID: IJNRD_181925

Published Paper Id: IJNRD2207006

Downloads: 000122254

Research Area: Pharmacy

Author Type: Indian Author

Country: BANGALORE, KARNATAKA, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2207006.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2207006

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 12 | December 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.


For more details, refer to the official notice: UGC Public Notice


Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: December 2025

Current Issue: Volume 10 | Issue 12 | December 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Dec-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details